{
  "meta": {
    "title": "13_Carcinogenesis_Paraneoplastic_Syndromes_And_Tumor_Markers",
    "url": "https://brainandscalpel.vercel.app/13-carcinogenesis-paraneoplastic-syndromes-and-tumor-markers-33ca2ada.html",
    "scrapedAt": "2025-11-30T12:33:25.738Z"
  },
  "questions": [
    {
      "text": "Which of the following tumors is best suited to study the mechanism of multi-step carcinogenesis?",
      "choices": [
        {
          "id": 1,
          "text": "Colon carcinoma"
        },
        {
          "id": 2,
          "text": "Melanoma"
        },
        {
          "id": 3,
          "text": "Thyroid carcinoma"
        },
        {
          "id": 4,
          "text": "Breast carcinoma"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Multi-step carcinogenesis</strong> is best studied in <strong>colon carcinoma.</strong></p>\n<p>The molecular model for the evolution of colorectal cancers is described as Fearon-Vogelstein&nbsp;adenoma-carcinoma sequence.</p><hr><h3>Related Pearl: Fearon-Vogelstein adenoma-carcinoma multistep model of colorectal neoplasia</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/36a7ff35752b47cb923b911ff3c3e18bx1280x1486.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4060",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following procarcinogens does not require metabolic activation?",
      "choices": [
        {
          "id": 1,
          "text": "Cyclophosphamide"
        },
        {
          "id": 2,
          "text": "Benzidene"
        },
        {
          "id": 3,
          "text": "3-Methylcholanthrene"
        },
        {
          "id": 4,
          "text": "Dimethylaminoazobenzene"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Cyclophosphamide</strong> is a <strong>directly-acting carcinogen</strong> that does not require metabolic activation.</p>\n<p>Carcinogens can be direct-acting or indirect-acting based on their activation.</p>\n<p><strong>Direct-acting</strong> carcinogens require no metabolic conversion to become carcinogenic. Most are weak carcinogens, but some are important because they are cancer chemotherapeutic drugs (e.g., alkylating agents). The direct-acting carcinogens include:</p>\n<ul>\n<li>Alkylating Agents:\n<ul>\n<li>β-Propiolactone</li>\n<li>Dimethyl sulfate</li>\n<li>Diepoxybutane</li>\n<li>Anticancer drugs (<strong>cyclophosphamide</strong>, chlorambucil, nitrosoureas, and others)</li>\n</ul>\n</li>\n<li>Acylating Agents:\n<ul>\n<li>1-Acetyl-imidazole</li>\n<li>Dimethylcarbamyl chloride</li>\n</ul>\n</li>\n</ul>\n<p><strong>Indirect-acting</strong> carcinogens (<strong>procarcinogens</strong>) are chemicals that require <strong>metabolic conversion</strong> to become active carcinogens. The carcinogenic product of metabolism is called an <strong>ultimate carcinogen</strong>. The indirect-acting carcinogens include:</p>\n<ul>\n<li>Polycyclic and heterocyclic aromatic hydrocarbons:\n<ul>\n<li>Benz[a]anthracene</li>\n<li>Benzo[a]pyrene</li>\n<li>Dibenz[a,h]anthracene</li>\n<li><strong>3-Methylcholanthrene</strong></li>\n<li>7,12-Dimethylbenz[a]anthracene</li>\n</ul>\n</li>\n<li>Aromatic amines, amides, azo dyes:\n<ul>\n<li>2-Naphthylamine (β-naphthylamine)</li>\n<li><strong>Benzidine</strong></li>\n<li>2-Acetylaminofluorene</li>\n<li><strong>Dimethylaminoazobenzene</strong> (butter yellow)</li>\n</ul>\n</li>\n<li>Natural plant and microbial products:\n<ul>\n<li>Aflatoxin B1</li>\n<li>Griseofulvin</li>\n<li>Cycasin</li>\n<li>Safrole</li>\n<li>Betel nuts</li>\n<li>Others</li>\n<li>Nitrosamine and amides</li>\n<li>Vinyl chloride, nickel, chromium</li>\n<li>Insecticides, fungicides</li>\n<li>Polychlorinated biphenyls</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4105",
      "difficulty": "medium"
    },
    {
      "text": "A 45-year-old man presents with a hyperpigmented lesion on his face. He is a farmer by occupation and works for long hours with sun exposure. He is at increased risk for all of the following except:",
      "choices": [
        {
          "id": 1,
          "text": "Squamous cell carcinoma"
        },
        {
          "id": 2,
          "text": "Basal cell carcinoma"
        },
        {
          "id": 3,
          "text": "Seborrheic keratosis"
        },
        {
          "id": 4,
          "text": "Actinic keratosis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Seborrheic keratosis</strong> is <strong>not </strong>associated with exposure to ultraviolet (UV) rays from sun exposure.</p>\n<p><strong>UV rays</strong> derived from sun exposure are associated with the increased incidence of:</p>\n<ul>\n<li><strong>Squamous cell carcinoma</strong></li>\n<li><strong>Basal cell carcinoma</strong></li>\n<li>Melanoma of the skin</li>\n</ul>\n<p><strong>Actinic keratosis</strong> is a <strong>precancerous</strong> skin condition that can cause squamous cell cancer if untreated.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4106",
      "difficulty": "medium"
    },
    {
      "text": "Which form of radiation is responsible for cutaneous cancer?",
      "choices": [
        {
          "id": 1,
          "text": "Only UVA"
        },
        {
          "id": 2,
          "text": "Only UVB"
        },
        {
          "id": 3,
          "text": "Both UVB and UVC"
        },
        {
          "id": 4,
          "text": "Both UVA and UVC"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>UVB</strong> (ultraviolet B)&nbsp;causes&nbsp;<strong>cutaneous cancers&nbsp;</strong>due to the formation of <strong>pyrimidine dimers</strong> in DNA.&nbsp;</p>\n<p>When DNA absorbs energy from UVB, there is a&nbsp;<strong>covalent crosslinking</strong> of <strong>pyrimidine bases</strong> and distortion of the DNA helix. This prevents proper pairing of the dimer with bases in the opposite DNA strand.&nbsp;</p>\n<p>Normally, these defects&nbsp;are repaired by&nbsp;<strong>nucleotide excision repair</strong> pathway.&nbsp;Defects in nucleotide excision repair pathway result in <strong>xeroderma pigmentosum.</strong></p>\n<p><strong>UV</strong> portion of the <strong>solar spectrum</strong> is divided into three wavelength ranges:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Spectrum</strong></td>\n<td><strong>Wavelength</strong></td>\n</tr>\n<tr>\n<td>UVA</td>\n<td>320-400 nm</td>\n</tr>\n<tr>\n<td>UVB</td>\n<td>280-320 nm</td>\n</tr>\n<tr>\n<td>UVC</td>\n<td>200-280 nm</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Note: UVC is the most potent mutagen but is not considered significant as it is filtered out by the ozone layer.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4108",
      "difficulty": "easy"
    },
    {
      "text": "Individuals with repeated exposure to ionizing radiation are at increased risk of which of the following malignancies?",
      "choices": [
        {
          "id": 1,
          "text": "Hodgkin lymphoma"
        },
        {
          "id": 2,
          "text": "Myeloid leukemia"
        },
        {
          "id": 3,
          "text": "Malignant melanoma"
        },
        {
          "id": 4,
          "text": "Squamous cell carcinoma"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Individuals with repeated <strong>exposure</strong> to <strong>ionizing radiation</strong> are at increased risk of&nbsp;<strong>myeloid leukemia.</strong></p>\n<p><strong>Carcinogenic radiations</strong> include:</p>\n<ul>\n<li><strong>Electromagnetic</strong>&nbsp;radiation -\n<ul>\n<li>X-rays</li>\n<li>&gamma; rays</li>\n</ul>\n</li>\n<li><strong>Particulate&nbsp;</strong>radiation -&nbsp;\n<ul>\n<li>&alpha; particles</li>\n<li>&beta; particles</li>\n<li>Protons</li>\n<li>Neutrons</li>\n</ul>\n</li>\n</ul>\n<p><strong>Cancers</strong> due to ionizing radiation:</p>\n<ul>\n<li>Most frequent - myeloid leukemia and thyroid cancer</li>\n<li>Intermediate frequency - cancers of breast, lungs, and salivary glands</li>\n<li>Relatively resistant cancers - cancers of skin, bone, and gastrointestinal tract</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4109",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following tumors is not caused by microbes?",
      "choices": [
        {
          "id": 1,
          "text": "Burkitt lymphoma"
        },
        {
          "id": 2,
          "text": "Castleman's disease"
        },
        {
          "id": 3,
          "text": "Adenocarcinoma lung"
        },
        {
          "id": 4,
          "text": "Primary effusion lymphoma"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Adenocarcinoma carcinoma</strong> of the <strong>lung </strong>is not associated with microbial etiopathogenesis. It is associated with <strong>smoking</strong> and <strong>genetic</strong> <strong>predispositions</strong>.</p><hr><h3>Related Pearl: Oncoviruses and the cancers associated with them</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Virus</strong></p>\n</td>\n<td>\n<p><strong>Genome</strong></p>\n</td>\n<td>\n<p><strong>Associated cancers&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatitis B</p>\n<p>(HBV)</p>\n</td>\n<td>\n<p>DNA</p>\n</td>\n<td>\n<p>Hepatocarcinoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatitis C</p>\n<p>(HCV)</p>\n</td>\n<td>\n<p>RNA</p>\n</td>\n<td>\n<p>Hepatocarcinoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Human</p>\n<p>T-</p>\n<p>lymphotropic</p>\n<p>virus (HTLV)</p>\n</td>\n<td>\n<p>RNA</p>\n</td>\n<td>\n<p>Adult T-cell leukemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Human</p>\n<p>papilloma</p>\n<p>viruses</p>\n<p>(HPV)</p>\n</td>\n<td>\n<p>DNA</p>\n</td>\n<td>\n<p>Cervical cancer</p>\n<p>Oropharyngeal cancer</p>\n<p>Anogenital cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Kaposi&rsquo;s</p>\n<p>sarcoma-</p>\n<p>associated</p>\n<p>herpesvirus</p>\n<p>(HHV-8)</p>\n</td>\n<td>\n<p>DNA</p>\n</td>\n<td>\n<p>Kaposi&rsquo;s sarcoma, multicentric Castleman's disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Merkel cell polyomavirus</p>\n<p>(MCV)</p>\n</td>\n<td>\n<p>DNA</p>\n</td>\n<td>\n<p>Merkel cell carcinoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Epstein&ndash;Barr</p>\n<p>virus (EBV)</p>\n</td>\n<td>\n<p>DNA</p>\n</td>\n<td>\n<p>Burkitt&rsquo;s lymphoma, Hodgkin&rsquo;s lymphoma, Post-transplant lymphoproliferative disease, and Nasopharyngeal carcinoma.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Lymphomas with Etiology</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Etiological factor</strong></p>\n</td>\n<td>\n<p><strong>Lymphoid neoplasm</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>Helicobacter pylori</em></p>\n</td>\n<td>\n<p>Gastric MALToma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>EBV</p>\n</td>\n<td>\n<p>Burkitt's lymphoma</p>\n<p>Post&ndash;organ transplant lymphoma</p>\n<p>Primary CNS diffuse large B cell lymphoma</p>\n<p>Hodgkin's disease (Mixed cellularity and lymphocyte depleted)</p>\n<p>Extranodal NK/T cell lymphoma, nasal type</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HIV</p>\n</td>\n<td>\n<p>Diffuse large B cell lymphoma</p>\n<p>Burkitt's lymphoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatitis C</p>\n</td>\n<td>\n<p>Lymphoplasmacytic lymphoma (Waldenstrom's macroglobulinemia)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HHV 8</p>\n</td>\n<td>\n<p>Primary effusion lymphoma</p>\n<p>Kaposi sarcoma</p>\n<p>Multicentric Castleman's disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Gluten sensitivity / Celiac disease</p>\n</td>\n<td>\n<p>Enteropathy-associated T-cell lymphoma (small intestine)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Severe T-cell deficiency</p>\n</td>\n<td>\n<p>B-cell lymphomas</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HTLV-1</p>\n</td>\n<td>\n<p>Adult T-cell leukemia/lymphoma</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>EBV:&nbsp;Epstein&ndash;Barr virus</p>\n<p>HHV 8: Human herpesvirus-8</p>\n<p>HTLV:&nbsp;Human T-cell leukemia/lymphoma virus&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4111",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following malignancies is caused by HTLV-1?",
      "choices": [
        {
          "id": 1,
          "text": "Adult T-cell leukemia/ lymphoma"
        },
        {
          "id": 2,
          "text": "Enteropathy associated T-cell lymphoma"
        },
        {
          "id": 3,
          "text": "Diffuse large B cell lymphoma"
        },
        {
          "id": 4,
          "text": "B cell lymphomas"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Human T-cell leukemia-lymphoma virus (<strong>HTLV-1</strong>) causes adult T-cell leukemia/lymphoma (<strong>ATLL</strong>).</p>\n<p>HTLV-1<strong>&nbsp;</strong>encodes the viral protein <strong>Tax</strong>,<strong>&nbsp;</strong>which leads to polyclonal expansion of T cells. It exhibits tropism for CD4+ T cells.</p>\n<p>Human infection requires transmission of infected T cells through sexual intercourse, blood products or breast feeding. Leukemia develops only in 3-5% of infected individuals, typically after a long latent period of 40-60 years.</p><hr><h3>Related Pearl: Oncoviruses and the cancers associated with them</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Virus</strong></p>\n</td>\n<td>\n<p><strong>Genome</strong></p>\n</td>\n<td>\n<p><strong>Associated cancers&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatitis B</p>\n<p>(HBV)</p>\n</td>\n<td>\n<p>DNA</p>\n</td>\n<td>\n<p>Hepatocarcinoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatitis C</p>\n<p>(HCV)</p>\n</td>\n<td>\n<p>RNA</p>\n</td>\n<td>\n<p>Hepatocarcinoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Human</p>\n<p>T-</p>\n<p>lymphotropic</p>\n<p>virus (HTLV)</p>\n</td>\n<td>\n<p>RNA</p>\n</td>\n<td>\n<p>Adult T-cell leukemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Human</p>\n<p>papilloma</p>\n<p>viruses</p>\n<p>(HPV)</p>\n</td>\n<td>\n<p>DNA</p>\n</td>\n<td>\n<p>Cervical cancer</p>\n<p>Oropharyngeal cancer</p>\n<p>Anogenital cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Kaposi&rsquo;s</p>\n<p>sarcoma-</p>\n<p>associated</p>\n<p>herpesvirus</p>\n<p>(HHV-8)</p>\n</td>\n<td>\n<p>DNA</p>\n</td>\n<td>\n<p>Kaposi&rsquo;s sarcoma, multicentric Castleman's disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Merkel cell polyomavirus</p>\n<p>(MCV)</p>\n</td>\n<td>\n<p>DNA</p>\n</td>\n<td>\n<p>Merkel cell carcinoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Epstein&ndash;Barr</p>\n<p>virus (EBV)</p>\n</td>\n<td>\n<p>DNA</p>\n</td>\n<td>\n<p>Burkitt&rsquo;s lymphoma, Hodgkin&rsquo;s lymphoma, Post-transplant lymphoproliferative disease, and Nasopharyngeal carcinoma.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Lymphomas with Etiology</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Etiological factor</strong></p>\n</td>\n<td>\n<p><strong>Lymphoid neoplasm</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>Helicobacter pylori</em></p>\n</td>\n<td>\n<p>Gastric MALToma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>EBV</p>\n</td>\n<td>\n<p>Burkitt's lymphoma</p>\n<p>Post&ndash;organ transplant lymphoma</p>\n<p>Primary CNS diffuse large B cell lymphoma</p>\n<p>Hodgkin's disease (Mixed cellularity and lymphocyte depleted)</p>\n<p>Extranodal NK/T cell lymphoma, nasal type</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HIV</p>\n</td>\n<td>\n<p>Diffuse large B cell lymphoma</p>\n<p>Burkitt's lymphoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatitis C</p>\n</td>\n<td>\n<p>Lymphoplasmacytic lymphoma (Waldenstrom's macroglobulinemia)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HHV 8</p>\n</td>\n<td>\n<p>Primary effusion lymphoma</p>\n<p>Kaposi sarcoma</p>\n<p>Multicentric Castleman's disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Gluten sensitivity / Celiac disease</p>\n</td>\n<td>\n<p>Enteropathy-associated T-cell lymphoma (small intestine)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Severe T-cell deficiency</p>\n</td>\n<td>\n<p>B-cell lymphomas</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HTLV-1</p>\n</td>\n<td>\n<p>Adult T-cell leukemia/lymphoma</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>EBV:&nbsp;Epstein&ndash;Barr virus</p>\n<p>HHV 8: Human herpesvirus-8</p>\n<p>HTLV:&nbsp;Human T-cell leukemia/lymphoma virus&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4114",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following pairs of HPV oncoproteins and target genes are correctly matched?",
      "choices": [
        {
          "id": 1,
          "text": "E6-RB, E7-p53"
        },
        {
          "id": 2,
          "text": "E6-p53, E7-RB"
        },
        {
          "id": 3,
          "text": "E5-RB, E6-p53"
        },
        {
          "id": 4,
          "text": "E5-p53, E6-RB"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The<strong> target genes</strong> for viral oncoproteins of human papilloma virus (<strong>HPV</strong>) are as follows:</p>\n<ul>\n<li>E6 - p53</li>\n<li>E7 - RB</li>\n</ul>\n<p>The image given below shows the functions of the E6 and E7 oncoproteins of HPV.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/08c5dd0f1d66435f9b8c7e3f4b47172ex1280x1382.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4116",
      "difficulty": "easy"
    },
    {
      "text": "A 13-year-old child presents to the OPD with fever, pharyngitis, and cervical lymphadenopathy. Peripheral smear showed a predominance of lymphocytes. The heterophile agglutination test is positive. The causative organism of this condition is not implicated in which of the following tumors?",
      "choices": [
        {
          "id": 1,
          "text": "Burkitt lymphoma"
        },
        {
          "id": 2,
          "text": "Hodgkin's lymphoma"
        },
        {
          "id": 3,
          "text": "Nasopharyngeal carcinoma"
        },
        {
          "id": 4,
          "text": "Follicular lymphoma"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The clinical scenario is suggestive of <strong>infectious mononucleosis</strong> caused by <strong>Epstein-Barr virus. </strong>This virus<strong> </strong>is not implicated in follicular lymphoma<strong>.</strong></p>\n<p>Epstein–Barr virus (EBV), a member of the <strong>herpesvirus</strong> family, has been implicated in:</p>\n<ul>\n<li>African form of <strong>Burkitt lymphoma</strong></li>\n<li>B-cell lymphomas in immunosuppressed</li>\n<li>A subset of <strong>Hodgkin lymphoma</strong></li>\n<li><strong>Nasopharyngeal carcinoma</strong></li>\n<li>Gastric carcinoma - most common EBV associated malignancy</li>\n<li>T-cell lymphoma and natural killer (NK) cell lymphoma</li>\n</ul><hr><h3>Related Pearl: Lymphomas with Etiology</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Etiological factor</strong></p>\n</td>\n<td>\n<p><strong>Lymphoid neoplasm</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>Helicobacter pylori</em></p>\n</td>\n<td>\n<p>Gastric MALToma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>EBV</p>\n</td>\n<td>\n<p>Burkitt's lymphoma</p>\n<p>Post&ndash;organ transplant lymphoma</p>\n<p>Primary CNS diffuse large B cell lymphoma</p>\n<p>Hodgkin's disease (Mixed cellularity and lymphocyte depleted)</p>\n<p>Extranodal NK/T cell lymphoma, nasal type</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HIV</p>\n</td>\n<td>\n<p>Diffuse large B cell lymphoma</p>\n<p>Burkitt's lymphoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatitis C</p>\n</td>\n<td>\n<p>Lymphoplasmacytic lymphoma (Waldenstrom's macroglobulinemia)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HHV 8</p>\n</td>\n<td>\n<p>Primary effusion lymphoma</p>\n<p>Kaposi sarcoma</p>\n<p>Multicentric Castleman's disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Gluten sensitivity / Celiac disease</p>\n</td>\n<td>\n<p>Enteropathy-associated T-cell lymphoma (small intestine)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Severe T-cell deficiency</p>\n</td>\n<td>\n<p>B-cell lymphomas</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HTLV-1</p>\n</td>\n<td>\n<p>Adult T-cell leukemia/lymphoma</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>EBV:&nbsp;Epstein&ndash;Barr virus</p>\n<p>HHV 8: Human herpesvirus-8</p>\n<p>HTLV:&nbsp;Human T-cell leukemia/lymphoma virus&nbsp;</p><hr><h3>Related Pearl: Oncoviruses and the cancers associated with them</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Virus</strong></p>\n</td>\n<td>\n<p><strong>Genome</strong></p>\n</td>\n<td>\n<p><strong>Associated cancers&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatitis B</p>\n<p>(HBV)</p>\n</td>\n<td>\n<p>DNA</p>\n</td>\n<td>\n<p>Hepatocarcinoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatitis C</p>\n<p>(HCV)</p>\n</td>\n<td>\n<p>RNA</p>\n</td>\n<td>\n<p>Hepatocarcinoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Human</p>\n<p>T-</p>\n<p>lymphotropic</p>\n<p>virus (HTLV)</p>\n</td>\n<td>\n<p>RNA</p>\n</td>\n<td>\n<p>Adult T-cell leukemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Human</p>\n<p>papilloma</p>\n<p>viruses</p>\n<p>(HPV)</p>\n</td>\n<td>\n<p>DNA</p>\n</td>\n<td>\n<p>Cervical cancer</p>\n<p>Oropharyngeal cancer</p>\n<p>Anogenital cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Kaposi&rsquo;s</p>\n<p>sarcoma-</p>\n<p>associated</p>\n<p>herpesvirus</p>\n<p>(HHV-8)</p>\n</td>\n<td>\n<p>DNA</p>\n</td>\n<td>\n<p>Kaposi&rsquo;s sarcoma, multicentric Castleman's disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Merkel cell polyomavirus</p>\n<p>(MCV)</p>\n</td>\n<td>\n<p>DNA</p>\n</td>\n<td>\n<p>Merkel cell carcinoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Epstein&ndash;Barr</p>\n<p>virus (EBV)</p>\n</td>\n<td>\n<p>DNA</p>\n</td>\n<td>\n<p>Burkitt&rsquo;s lymphoma, Hodgkin&rsquo;s lymphoma, Post-transplant lymphoproliferative disease, and Nasopharyngeal carcinoma.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4117",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements about Epstein-Barr virus is incorrect?",
      "choices": [
        {
          "id": 1,
          "text": "EBV infection always results in Burkitt lymphoma"
        },
        {
          "id": 2,
          "text": "It uses the complement receptor CD21 to attach and infect B cells"
        },
        {
          "id": 3,
          "text": "It is implicated in B-cell lymphomas in immunosuppressed people"
        },
        {
          "id": 4,
          "text": "It is a potent inducer of B-cell growth and transformation"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Epstein-Barr<strong> </strong>virus (<strong>EBV</strong>) infection does not always result in Burkitt lymphoma.</p>\n<p>EBV infection is highly prevalent even in areas where Burkitt lymphoma is not found. It commonly causes <strong>infectious mononucleosis</strong>. </p>\n<p>EBV uses the complement receptor <strong>CD21</strong> to attach to and infect B cells. EBV genome <strong>triggers</strong> B-cell signaling pathways inducing <strong>B-cell growth</strong> and transformation. </p>\n<p>The infection of B cells is <strong>latent </strong>as there is no viral replication and the cells are not killed. However, B cells latently infected with EBV express <strong>viral proteins</strong> that result in the ability to<strong> propagate indefinitely</strong> in vitro. In the <strong>absence</strong> of<strong> T-cell</strong> immunity, EBV-infected B cells can rapidly grow out as <strong>aggressive</strong> B-cell <strong>tumors</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4118",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following pathogens is implicated in the causation of primary effusion lymphoma and Castleman disease?",
      "choices": [
        {
          "id": 1,
          "text": "JC virus"
        },
        {
          "id": 2,
          "text": "Polyoma BK virus"
        },
        {
          "id": 3,
          "text": "EBV"
        },
        {
          "id": 4,
          "text": "HHV 8"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Human herpesvirus 8 (<strong>HHV8</strong>) is a gamma-herpesvirus associated with Kaposi sarcoma, multicentric <strong>Castleman</strong> disease, and <strong>primary effusion</strong> <strong>lymphoma</strong>.</p>\n<p>They are lymphoproliferative diseases that are most commonly observed in <strong>immunocompromised</strong> individuals. The viral genome expresses genes responsible for inhibition of apoptosis, cell cycle entry, and angiogenesis.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4120",
      "difficulty": "easy"
    },
    {
      "text": "A patient presents with abdominal distension and intermittent fever. Peripheral smear findings are normal. A tumor is resected and the histopathology image of the resected lymph node is shown below. What is the most probable diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Angiolymphoma"
        },
        {
          "id": 2,
          "text": "Hodgkin's lymphoma"
        },
        {
          "id": 3,
          "text": "IgG4-related disease"
        },
        {
          "id": 4,
          "text": "Castleman disease"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical scenario and histopathological image showing <strong>follicular hyperplasia</strong> of lymph nodes are suggestive of <strong>Castleman disease</strong>.</p>\n<p><strong>Castleman disease </strong>(angiofollicular&nbsp;lymph node hyperplasia) is a lymphoproliferative disorder that can be associated with <strong>HHV-8</strong> (multicentric Castleman disease or MCD) or idiopathic (unicentric Castleman disease or UCD)</p>\n<p>There are 3 major histological <strong>subtypes</strong>:</p>\n<ul>\n<li><strong>Hypervascular</strong>&nbsp;(UCD) - &nbsp;\n<ul>\n<li>Lollipop appearance - atrophic germinal centers with radially penetrating blood vessels</li>\n<li>Onion skin appearance of mantle zone around germinal centers</li>\n</ul>\n</li>\n<li><strong>Plasma cell</strong> subtype (UCD or MCD) -&nbsp;hypertrophic germinal centers, increased vascularity</li>\n<li><strong>Mixed</strong> variant (MCD) - mix of hypervascular and plasma cell subtype features in the same lymph node</li>\n</ul>\n<p>The <strong>clinical features</strong> include:</p>\n<ul>\n<li>Multiple enlarged lymph nodes</li>\n<li>Night sweats</li>\n<li>Weight loss</li>\n<li>Weakness and fatigue</li>\n<li>Hepatosplenomegaly&nbsp;</li>\n</ul>\n<p>As this condition is associated with elevated levels of IL-6, the treatment involves&nbsp;<strong>IL-6 inhibitors </strong>like <strong>siltuximab </strong>and<strong> tocilizumab.</strong></p>\n<p>Note:<strong>&nbsp;</strong>Hodgkin's lymphoma has characteristic <strong>Reed-Sternberg cells</strong> in the histopathological section of lymph nodes.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/e8c76803f2174861ab20e9539750dd3d.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7121",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is an EBV oncogene behaving like a constitutively active CD40 receptor?",
      "choices": [
        {
          "id": 1,
          "text": "LMP-1"
        },
        {
          "id": 2,
          "text": "EBNA-2"
        },
        {
          "id": 3,
          "text": "EBNA-1"
        },
        {
          "id": 4,
          "text": "LMP-2"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>LMP-1 </strong>is an<strong> EBV oncogene </strong>that<strong> </strong>behaves like a constitutively <strong>active CD40 receptor</strong>.</p>\n<p>The CD40 receptor-like activity stimulates B-cell growth. LMP-1 activates the <strong>NF-κB</strong> and <strong>JAK</strong> / <strong>STAT</strong> signaling pathways and promotes B-cell survival. It also prevents apoptosis by activating <strong>BCL2</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4121",
      "difficulty": "medium"
    },
    {
      "text": "Helicobacter pylori increases the risk of development of which of the following conditions?<div class='question-desc-html'><ol>\n<li>Peptic ulcer</li>\n<li>Barrett's esophagus</li>\n<li>Gastric adenocarcinoma</li>\n<li>MALT lymphoma</li>\n<li>Adenocarcinoma of esophagus</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 3, 5"
        },
        {
          "id": 2,
          "text": "2, 4, 5"
        },
        {
          "id": 3,
          "text": "1, 2, 4"
        },
        {
          "id": 4,
          "text": "1, 3, 4"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong><em>Helicobacter pylori</em></strong> is implicated in the following conditions:</p>\n<ul>\n<li>Peptic ulcer</li>\n<li>Gastric adenocarcinoma&nbsp;- preceded by chronic gastritis, gastric atrophy, intestinal metaplasia, and dysplasia</li>\n<li>MALT lymphoma of the stomach - through polyclonal B cell proliferation</li>\n</ul>\n<p><em>Helicobacter pylori</em>&nbsp;is<em>&nbsp;</em><strong>protective</strong> for:</p>\n<ul>\n<li>Barrett's esophagus</li>\n<li>Adenocarcinoma of esophagus</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4122",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is the most common endocrinopathy caused by tumors?",
      "choices": [
        {
          "id": 1,
          "text": "Cushing syndrome"
        },
        {
          "id": 2,
          "text": "Osteomalacia"
        },
        {
          "id": 3,
          "text": "SIADH"
        },
        {
          "id": 4,
          "text": "Hypercalcemia"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Cushing syndrome </strong>is the most common <strong>endocrinopathy&nbsp;</strong>caused by tumors<strong>.</strong></p>\n<p>Endocrinopathy refers to <strong>ectopic hormone </strong>production by <strong>non-endocrine</strong> <strong>tumors</strong>. Approximately, 50% of the individuals with Cushing syndrome as endocrinopathy have carcinoma of the lung, chiefly the <strong>small-cell type</strong>.</p>\n<p><strong>Hypercalcemia </strong>is the most common <strong>paraneoplastic</strong> syndrome.&nbsp;Cancer-associated hypercalcemia occurs due to:</p>\n<ul>\n<li><strong>Osteolysis</strong> induced by cancer - due to primary or secondary involvement of the skeleton by tumor</li>\n<li>Production of <strong>calcemic humoral</strong> substances by <strong>extraosseous</strong> neoplasms - for example, parathyroid hormone-related protein. Only this mechanism is considered to be paraneoplastic.</li>\n</ul><hr><h3>Related Pearl: Paraneoplastic Syndromes and Underlying Cancers</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Clinical Syndromes/&nbsp;</strong></p>\n<p><strong>Endocrinopathies</strong></p>\n</td>\n<td>\n<p><strong>Major Forms of Underlying Cancer</strong></p>\n</td>\n<td>\n<p><strong>Causal Mechanism</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cushing Syndrome</p>\n</td>\n<td>\n<p>Small-cell carcinoma of lung</p>\n<p>Pancreatic carcinoma</p>\n<p>Neural tumours</p>\n<p>Renal carcinoma</p>\n</td>\n<td>\n<p>ACTH or ACTH- like substance</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Syndrome of inappropriate antidiuretic hormone secretion (SIADH)</p>\n</td>\n<td>\n<p>Small-cell carcinoma of lung</p>\n<p>Intracranial neoplasms</p>\n</td>\n<td>\n<p>Antidiuretic hormone or atrial natriuretic hormones</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypercalcemia</p>\n</td>\n<td>\n<p>Squamous cell carcinoma of lung</p>\n<p>Breast carcinoma</p>\n<p>Renal carcinoma</p>\n<p>Adult T-cell leukemia/lymphoma</p>\n</td>\n<td>\n<p>Parathyroid hormone-related protein(PTHRP), TGF-a, TNF, IL-1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypoglycaemia</p>\n</td>\n<td>\n<p>Ovarian carcinoma</p>\n<p>Fibrosarcoma</p>\n<p>Other mesenchymal sarcomas</p>\n</td>\n<td>\n<p>Insulin or insulin-like substance</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Polycythemia</p>\n</td>\n<td>\n<p>Renal carcinoma</p>\n<p>Cerebellar haemangioma</p>\n<p>Hepatocellular carcinoma</p>\n</td>\n<td>\n<p>Erythropoietin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Osteomalacia</p>\n</td>\n<td>\n<p>Phosphaturic mesenchymal tumor</p>\n</td>\n<td>\n<p>FGF-23</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Disseminated intrvascular coagulation</p>\n</td>\n<td>\n<p>Acute promyelocytic leukemia</p>\n<p>Prostatic carcinoma</p>\n</td>\n<td>\n<p>Tumor products activate clotting</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>ACTH:&nbsp;Adrenocorticotropic hormone&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4126",
      "difficulty": "medium"
    },
    {
      "text": "Patients with which of the following tumors present with pure red cell aplasia as a paraneoplastic manifestation?",
      "choices": [
        {
          "id": 1,
          "text": "Pancreatic carcinoma"
        },
        {
          "id": 2,
          "text": "Renal carcinoma"
        },
        {
          "id": 3,
          "text": "Thymoma"
        },
        {
          "id": 4,
          "text": "Acute myeloid leukemia"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Thymoma </strong>often presents with<strong> pure red cell aplasia </strong>as a paraneoplastic manifestation.</p>\n<p>Thymomas are unusual neoplasms of <strong>thymic</strong> <strong>epithelial</strong> tissue, ranging from small indolent tumors to aggressive thymic carcinomas.</p>\n<p><strong>Pure red cell aplasia</strong> is a rare cause of anemia, caused by the&nbsp;<strong>absence</strong> of RBC&nbsp;<strong>precursors</strong> in the bone marrow.&nbsp;<strong>Causes</strong>&nbsp;of&nbsp;pure&nbsp;red cell aplasia&nbsp;include:</p>\n<ul>\n<li>Neoplasms -&nbsp;thymomas&nbsp;and large granular lymphocytic&nbsp;leukemia</li>\n<li>Drug exposure - phenytoin, azathioprine, and isoniazid</li>\n<li>Auto-immune disorders - neutralizing antibodies against erythropoietin</li>\n<li>Parvovirus&nbsp;infection</li>\n<li>Hereditary -&nbsp;Diamond Blackfan syndrome</li>\n</ul><hr><h3>Related Pearl: Paraneoplastic Syndromes and Underlying Cancers</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Clinical Syndromes/&nbsp;</strong></p>\n<p><strong>Endocrinopathies</strong></p>\n</td>\n<td>\n<p><strong>Major Forms of Underlying Cancer</strong></p>\n</td>\n<td>\n<p><strong>Causal Mechanism</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cushing Syndrome</p>\n</td>\n<td>\n<p>Small-cell carcinoma of lung</p>\n<p>Pancreatic carcinoma</p>\n<p>Neural tumours</p>\n<p>Renal carcinoma</p>\n</td>\n<td>\n<p>ACTH or ACTH- like substance</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Syndrome of inappropriate antidiuretic hormone secretion (SIADH)</p>\n</td>\n<td>\n<p>Small-cell carcinoma of lung</p>\n<p>Intracranial neoplasms</p>\n</td>\n<td>\n<p>Antidiuretic hormone or atrial natriuretic hormones</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypercalcemia</p>\n</td>\n<td>\n<p>Squamous cell carcinoma of lung</p>\n<p>Breast carcinoma</p>\n<p>Renal carcinoma</p>\n<p>Adult T-cell leukemia/lymphoma</p>\n</td>\n<td>\n<p>Parathyroid hormone-related protein(PTHRP), TGF-a, TNF, IL-1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypoglycaemia</p>\n</td>\n<td>\n<p>Ovarian carcinoma</p>\n<p>Fibrosarcoma</p>\n<p>Other mesenchymal sarcomas</p>\n</td>\n<td>\n<p>Insulin or insulin-like substance</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Polycythemia</p>\n</td>\n<td>\n<p>Renal carcinoma</p>\n<p>Cerebellar haemangioma</p>\n<p>Hepatocellular carcinoma</p>\n</td>\n<td>\n<p>Erythropoietin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Osteomalacia</p>\n</td>\n<td>\n<p>Phosphaturic mesenchymal tumor</p>\n</td>\n<td>\n<p>FGF-23</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Disseminated intrvascular coagulation</p>\n</td>\n<td>\n<p>Acute promyelocytic leukemia</p>\n<p>Prostatic carcinoma</p>\n</td>\n<td>\n<p>Tumor products activate clotting</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>ACTH:&nbsp;Adrenocorticotropic hormone&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4127",
      "difficulty": "medium"
    },
    {
      "text": "Which subtype of acute myeloid leukemia presents with disseminated intravascular coagulation as a paraneoplastic manifestation?",
      "choices": [
        {
          "id": 1,
          "text": "AML minimally differentiated"
        },
        {
          "id": 2,
          "text": "Acute promyelocytic leukemia"
        },
        {
          "id": 3,
          "text": "Acute myelomonocytic leukemia"
        },
        {
          "id": 4,
          "text": "Acute megakaryoblastic leukemia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Disseminated intravascular coagulation&nbsp;(<strong>DIC</strong>) as a paraneoplastic syndrome is most commonly associated with <strong>acute promyelocytic leukemia&nbsp;</strong>(APL) and<strong> prostatic adenocarcinoma.</strong></p>\n<p>Major determinants of coagulopathy in APL are endogenous factors of the malignant leukemic cells and their interaction with host defense mechanisms.</p>\n<p><strong>Factors</strong> that cause coagulopathy include:</p>\n<ul>\n<li>Increased expression of procoagulant activity (PCA)</li>\n<li>Expression of fibrinolytic and proteolytic properties</li>\n<li>Secretion of pro-inflammatory cytokines - interleukin-1b (IL-1b) and tumor necrosis factor (TNF)</li>\n</ul><hr><h3>Related Pearl: Paraneoplastic Syndromes and Underlying Cancers</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Clinical Syndromes/&nbsp;</strong></p>\n<p><strong>Endocrinopathies</strong></p>\n</td>\n<td>\n<p><strong>Major Forms of Underlying Cancer</strong></p>\n</td>\n<td>\n<p><strong>Causal Mechanism</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cushing Syndrome</p>\n</td>\n<td>\n<p>Small-cell carcinoma of lung</p>\n<p>Pancreatic carcinoma</p>\n<p>Neural tumours</p>\n<p>Renal carcinoma</p>\n</td>\n<td>\n<p>ACTH or ACTH- like substance</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Syndrome of inappropriate antidiuretic hormone secretion (SIADH)</p>\n</td>\n<td>\n<p>Small-cell carcinoma of lung</p>\n<p>Intracranial neoplasms</p>\n</td>\n<td>\n<p>Antidiuretic hormone or atrial natriuretic hormones</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypercalcemia</p>\n</td>\n<td>\n<p>Squamous cell carcinoma of lung</p>\n<p>Breast carcinoma</p>\n<p>Renal carcinoma</p>\n<p>Adult T-cell leukemia/lymphoma</p>\n</td>\n<td>\n<p>Parathyroid hormone-related protein(PTHRP), TGF-a, TNF, IL-1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypoglycaemia</p>\n</td>\n<td>\n<p>Ovarian carcinoma</p>\n<p>Fibrosarcoma</p>\n<p>Other mesenchymal sarcomas</p>\n</td>\n<td>\n<p>Insulin or insulin-like substance</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Polycythemia</p>\n</td>\n<td>\n<p>Renal carcinoma</p>\n<p>Cerebellar haemangioma</p>\n<p>Hepatocellular carcinoma</p>\n</td>\n<td>\n<p>Erythropoietin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Osteomalacia</p>\n</td>\n<td>\n<p>Phosphaturic mesenchymal tumor</p>\n</td>\n<td>\n<p>FGF-23</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Disseminated intrvascular coagulation</p>\n</td>\n<td>\n<p>Acute promyelocytic leukemia</p>\n<p>Prostatic carcinoma</p>\n</td>\n<td>\n<p>Tumor products activate clotting</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>ACTH:&nbsp;Adrenocorticotropic hormone&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4128",
      "difficulty": "medium"
    },
    {
      "text": "A 60-year-old patient presents with loss of weight and appetite. On clinical examination, grade IV clubbing is evident. Imaging shows periosteal new bone formation and synovial effusion. Which of the following tumors is associated with this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Bronchogenic carcinoma"
        },
        {
          "id": 2,
          "text": "Carcinoma of the pancreas"
        },
        {
          "id": 3,
          "text": "Esophageal carcinoma"
        },
        {
          "id": 4,
          "text": "Acute myeloid leukaemia"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical history is suggestive of <strong>hypertrophic osteoarthropathy. </strong>It is commonly associated with <strong>bronchiogenic carcinoma.</strong></p>\n<p>Hypertrophic osteoarthropathy is characterised by the following:</p>\n<ul>\n<li><strong>Periosteal new bone formation</strong>, primarily at the distal ends of long bones, metatarsals, metacarpals, and proximal phalanges</li>\n<li><strong>Arthritis</strong> of the adjacent joints</li>\n<li><strong>Clubbing</strong> of the digits</li>\n</ul><hr><h3>Related Pearl: Paraneoplastic Syndromes and Underlying Cancers</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Clinical Syndromes/&nbsp;</strong></p>\n<p><strong>Endocrinopathies</strong></p>\n</td>\n<td>\n<p><strong>Major Forms of Underlying Cancer</strong></p>\n</td>\n<td>\n<p><strong>Causal Mechanism</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cushing Syndrome</p>\n</td>\n<td>\n<p>Small-cell carcinoma of lung</p>\n<p>Pancreatic carcinoma</p>\n<p>Neural tumours</p>\n<p>Renal carcinoma</p>\n</td>\n<td>\n<p>ACTH or ACTH- like substance</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Syndrome of inappropriate antidiuretic hormone secretion (SIADH)</p>\n</td>\n<td>\n<p>Small-cell carcinoma of lung</p>\n<p>Intracranial neoplasms</p>\n</td>\n<td>\n<p>Antidiuretic hormone or atrial natriuretic hormones</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypercalcemia</p>\n</td>\n<td>\n<p>Squamous cell carcinoma of lung</p>\n<p>Breast carcinoma</p>\n<p>Renal carcinoma</p>\n<p>Adult T-cell leukemia/lymphoma</p>\n</td>\n<td>\n<p>Parathyroid hormone-related protein(PTHRP), TGF-a, TNF, IL-1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypoglycaemia</p>\n</td>\n<td>\n<p>Ovarian carcinoma</p>\n<p>Fibrosarcoma</p>\n<p>Other mesenchymal sarcomas</p>\n</td>\n<td>\n<p>Insulin or insulin-like substance</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Polycythemia</p>\n</td>\n<td>\n<p>Renal carcinoma</p>\n<p>Cerebellar haemangioma</p>\n<p>Hepatocellular carcinoma</p>\n</td>\n<td>\n<p>Erythropoietin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Osteomalacia</p>\n</td>\n<td>\n<p>Phosphaturic mesenchymal tumor</p>\n</td>\n<td>\n<p>FGF-23</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Disseminated intrvascular coagulation</p>\n</td>\n<td>\n<p>Acute promyelocytic leukemia</p>\n<p>Prostatic carcinoma</p>\n</td>\n<td>\n<p>Tumor products activate clotting</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>ACTH:&nbsp;Adrenocorticotropic hormone&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4130",
      "difficulty": "easy"
    },
    {
      "text": "A 55-year-old patient presents with generalized tiredness, malaise, muscle weakness, and bone pain. Laboratory investigations reveal serum calcium to be 13 mg/dL.  Which of the following is lung cancers is implicated in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Squamous cell carcinoma of lung"
        },
        {
          "id": 2,
          "text": "Adenosquamous carcinoma of lung"
        },
        {
          "id": 3,
          "text": "Small cell carcinoma of lung"
        },
        {
          "id": 4,
          "text": "Large cell carcinoma of lung"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical history and laboratory investigations are suggestive of <strong>hypercalcemia.</strong>&nbsp;It is associated with<strong> squamous cell carcinoma </strong>of the<strong> lung.</strong></p>\n<p>Tumors associated with <strong>paraneoplastic hypercalcemia</strong>:</p>\n<ul>\n<li>Breast carcinoma</li>\n<li>Lung carcinoma</li>\n<li>Renal cell carcinoma</li>\n<li>Ovarian carcinoma</li>\n</ul><hr><h3>Related Pearl: Paraneoplastic Syndromes and Underlying Cancers</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Clinical Syndromes/&nbsp;</strong></p>\n<p><strong>Endocrinopathies</strong></p>\n</td>\n<td>\n<p><strong>Major Forms of Underlying Cancer</strong></p>\n</td>\n<td>\n<p><strong>Causal Mechanism</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cushing Syndrome</p>\n</td>\n<td>\n<p>Small-cell carcinoma of lung</p>\n<p>Pancreatic carcinoma</p>\n<p>Neural tumours</p>\n<p>Renal carcinoma</p>\n</td>\n<td>\n<p>ACTH or ACTH- like substance</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Syndrome of inappropriate antidiuretic hormone secretion (SIADH)</p>\n</td>\n<td>\n<p>Small-cell carcinoma of lung</p>\n<p>Intracranial neoplasms</p>\n</td>\n<td>\n<p>Antidiuretic hormone or atrial natriuretic hormones</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypercalcemia</p>\n</td>\n<td>\n<p>Squamous cell carcinoma of lung</p>\n<p>Breast carcinoma</p>\n<p>Renal carcinoma</p>\n<p>Adult T-cell leukemia/lymphoma</p>\n</td>\n<td>\n<p>Parathyroid hormone-related protein(PTHRP), TGF-a, TNF, IL-1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypoglycaemia</p>\n</td>\n<td>\n<p>Ovarian carcinoma</p>\n<p>Fibrosarcoma</p>\n<p>Other mesenchymal sarcomas</p>\n</td>\n<td>\n<p>Insulin or insulin-like substance</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Polycythemia</p>\n</td>\n<td>\n<p>Renal carcinoma</p>\n<p>Cerebellar haemangioma</p>\n<p>Hepatocellular carcinoma</p>\n</td>\n<td>\n<p>Erythropoietin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Osteomalacia</p>\n</td>\n<td>\n<p>Phosphaturic mesenchymal tumor</p>\n</td>\n<td>\n<p>FGF-23</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Disseminated intrvascular coagulation</p>\n</td>\n<td>\n<p>Acute promyelocytic leukemia</p>\n<p>Prostatic carcinoma</p>\n</td>\n<td>\n<p>Tumor products activate clotting</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>ACTH:&nbsp;Adrenocorticotropic hormone&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4131",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following paraneoplastic manifestations is likely to occur in a patient with a phosphaturic mesenchymal tumor?",
      "choices": [
        {
          "id": 1,
          "text": "Cushing syndrome"
        },
        {
          "id": 2,
          "text": "Osteomalacia"
        },
        {
          "id": 3,
          "text": "SIADH"
        },
        {
          "id": 4,
          "text": "Polycythemia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Phosphaturic mesenchymal tumor</strong> presents with <strong>osteomalacia</strong> as a paraneoplastic manifestation.</p>\n<p>Phosphaturic mesenchymal tumor is caused due to mutation of the <strong>FGF-23 gene</strong>.</p><hr><h3>Related Pearl: Paraneoplastic Syndromes and Underlying Cancers</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Clinical Syndromes/&nbsp;</strong></p>\n<p><strong>Endocrinopathies</strong></p>\n</td>\n<td>\n<p><strong>Major Forms of Underlying Cancer</strong></p>\n</td>\n<td>\n<p><strong>Causal Mechanism</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cushing Syndrome</p>\n</td>\n<td>\n<p>Small-cell carcinoma of lung</p>\n<p>Pancreatic carcinoma</p>\n<p>Neural tumours</p>\n<p>Renal carcinoma</p>\n</td>\n<td>\n<p>ACTH or ACTH- like substance</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Syndrome of inappropriate antidiuretic hormone secretion (SIADH)</p>\n</td>\n<td>\n<p>Small-cell carcinoma of lung</p>\n<p>Intracranial neoplasms</p>\n</td>\n<td>\n<p>Antidiuretic hormone or atrial natriuretic hormones</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypercalcemia</p>\n</td>\n<td>\n<p>Squamous cell carcinoma of lung</p>\n<p>Breast carcinoma</p>\n<p>Renal carcinoma</p>\n<p>Adult T-cell leukemia/lymphoma</p>\n</td>\n<td>\n<p>Parathyroid hormone-related protein(PTHRP), TGF-a, TNF, IL-1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypoglycaemia</p>\n</td>\n<td>\n<p>Ovarian carcinoma</p>\n<p>Fibrosarcoma</p>\n<p>Other mesenchymal sarcomas</p>\n</td>\n<td>\n<p>Insulin or insulin-like substance</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Polycythemia</p>\n</td>\n<td>\n<p>Renal carcinoma</p>\n<p>Cerebellar haemangioma</p>\n<p>Hepatocellular carcinoma</p>\n</td>\n<td>\n<p>Erythropoietin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Osteomalacia</p>\n</td>\n<td>\n<p>Phosphaturic mesenchymal tumor</p>\n</td>\n<td>\n<p>FGF-23</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Disseminated intrvascular coagulation</p>\n</td>\n<td>\n<p>Acute promyelocytic leukemia</p>\n<p>Prostatic carcinoma</p>\n</td>\n<td>\n<p>Tumor products activate clotting</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>ACTH:&nbsp;Adrenocorticotropic hormone&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4606",
      "difficulty": "medium"
    },
    {
      "text": "A 48-year-old obese female presents with skin changes in her axilla and neck as shown in the image. Which of the following tumors is not associated with this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Gastric carcinoma"
        },
        {
          "id": 2,
          "text": "Bladder carcinoma"
        },
        {
          "id": 3,
          "text": "Uterine carcinoma"
        },
        {
          "id": 4,
          "text": "Thymoma"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical picture is suggestive of<strong>&nbsp;acanthosis nigricans. </strong>It is not associated with thymoma.</p>\n<p>Acanthosis nigricans is a disorder characterized by gray-black patches of thickened, <strong>hyperkeratotic</strong> skin with a velvety appearance. The causal mechanism is immunologic due to secretion of<strong> epidermal growth factor.</strong></p>\n<p>Acanthosis nigricans is commonly associated with:</p>\n<ul>\n<li><strong>Gastric carcinoma</strong></li>\n<li>Lung carcinoma</li>\n<li><strong>Gynecological cancers</strong></li>\n<li>Breast carcinoma</li>\n<li><strong>Bladder carcinoma</strong></li>\n<li>Gallbladder and bile-duct carcinoma</li>\n<li>Acromegaly and gigantism</li>\n<li>Dermatomyositis</li>\n<li>Diabetes</li>\n<li>Hashimoto thyroiditis</li>\n<li>Lupus erythematosus</li>\n<li>Phenylketonuria</li>\n<li>Polycystic ovary syndrome</li>\n<li>Systemic sclerosis</li>\n<li>Wilson syndrome</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/c8285a5da2d94d10a7bff5f2e8f1d92a.jpg"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4132",
      "difficulty": "medium"
    },
    {
      "text": "A 45-year-old patient presents with headache, vertigo, tinnitus, and visual disturbance. On further evaluation, blood hemoglobin and hematocrit levels are found to be 18 g/dL and 62% respectively. Which of the following tumors does not present with these paraneoplastic manifestations?",
      "choices": [
        {
          "id": 1,
          "text": "Melanoma"
        },
        {
          "id": 2,
          "text": "Renal cell carcinoma"
        },
        {
          "id": 3,
          "text": "Cerebellar hemangioma"
        },
        {
          "id": 4,
          "text": "Hepatocellular carcinoma"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical history and laboratory investigations are suggestive of <strong>polycythemia</strong> which is not seen in&nbsp;melanoma&nbsp;as a paraneoplastic manifestation.</p>\n<p>Polycythemia, as a paraneoplastic syndrome, is mediated by <strong>erythropoietin</strong> (EPO). EPO is a glycoprotein that induces differentiation of erythrocyte colony-forming units in the bone marrow to promote red blood cell production.&nbsp;</p>\n<p>Under normal physiological conditions, EPO is produced by <strong>peritubular renal interstitial cells </strong>in response to<strong> local tissue hypoxia.</strong> However, in tumors, EPO production occurs in the neoplastic cells themselves.</p><hr><h3>Related Pearl: Malignancies Associated With Paraneoplastic Polycythemia</h3><ul>\n<li>Renal cell carcinoma</li>\n<li>Hepatoma</li>\n<li>Cerebellar hemangioma</li>\n<li>Adrenal cortical tumors</li>\n<li>Pheochromocytomas</li>\n<li>Virilizing ovarian tumors</li>\n<li>Wilms&rsquo; tumor</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4135",
      "difficulty": "medium"
    },
    {
      "text": "Which of these paraneoplastic syndromes is associated with small-cell carcinoma lung?",
      "choices": [
        {
          "id": 1,
          "text": "Osteomalacia"
        },
        {
          "id": 2,
          "text": "SIADH"
        },
        {
          "id": 3,
          "text": "Polycythemia"
        },
        {
          "id": 4,
          "text": "Hypercalcemia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Syndrome of inappropriate antidiuretic hormone (<strong>SIADH</strong>) is associated with <strong>small cell carcinoma</strong> of <strong>lung</strong>.</p><hr><h3>Related Pearl: Paraneoplastic Syndromes and Underlying Cancers</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Clinical Syndromes/&nbsp;</strong></p>\n<p><strong>Endocrinopathies</strong></p>\n</td>\n<td>\n<p><strong>Major Forms of Underlying Cancer</strong></p>\n</td>\n<td>\n<p><strong>Causal Mechanism</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cushing Syndrome</p>\n</td>\n<td>\n<p>Small-cell carcinoma of lung</p>\n<p>Pancreatic carcinoma</p>\n<p>Neural tumours</p>\n<p>Renal carcinoma</p>\n</td>\n<td>\n<p>ACTH or ACTH- like substance</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Syndrome of inappropriate antidiuretic hormone secretion (SIADH)</p>\n</td>\n<td>\n<p>Small-cell carcinoma of lung</p>\n<p>Intracranial neoplasms</p>\n</td>\n<td>\n<p>Antidiuretic hormone or atrial natriuretic hormones</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypercalcemia</p>\n</td>\n<td>\n<p>Squamous cell carcinoma of lung</p>\n<p>Breast carcinoma</p>\n<p>Renal carcinoma</p>\n<p>Adult T-cell leukemia/lymphoma</p>\n</td>\n<td>\n<p>Parathyroid hormone-related protein(PTHRP), TGF-a, TNF, IL-1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypoglycaemia</p>\n</td>\n<td>\n<p>Ovarian carcinoma</p>\n<p>Fibrosarcoma</p>\n<p>Other mesenchymal sarcomas</p>\n</td>\n<td>\n<p>Insulin or insulin-like substance</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Polycythemia</p>\n</td>\n<td>\n<p>Renal carcinoma</p>\n<p>Cerebellar haemangioma</p>\n<p>Hepatocellular carcinoma</p>\n</td>\n<td>\n<p>Erythropoietin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Osteomalacia</p>\n</td>\n<td>\n<p>Phosphaturic mesenchymal tumor</p>\n</td>\n<td>\n<p>FGF-23</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Disseminated intrvascular coagulation</p>\n</td>\n<td>\n<p>Acute promyelocytic leukemia</p>\n<p>Prostatic carcinoma</p>\n</td>\n<td>\n<p>Tumor products activate clotting</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>ACTH:&nbsp;Adrenocorticotropic hormone&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4136",
      "difficulty": "easy"
    },
    {
      "text": "A 60-year-old patient notices spontaneously appearing and disappearing painful, linearly arranged nodules in different parts of the body. Which of the following malignancies is not associated with this clinical presentation?",
      "choices": [
        {
          "id": 1,
          "text": "Uterine carcinoma"
        },
        {
          "id": 2,
          "text": "Pancreatic carcinoma"
        },
        {
          "id": 3,
          "text": "Bronchogenic carcinoma"
        },
        {
          "id": 4,
          "text": "Bladder carcinoma"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical presentation is suggestive of <strong>migratory thrombophlebitis</strong> (Trousseau syndrome) and it is not associated with <strong>bladder carcinoma.</strong></p>\n<p><strong>Trousseau syndrome&nbsp;</strong>may be encountered in association with deep-seated cancers, most often carcinomas of the <strong>pancreas </strong>or<strong> lung. </strong>It is caused by hypercoagulability leading to multiple repeated venous thromboembolism.</p>\n<p>Malignant brain tumors, hematological malignancies, and adenocarcinomas of the pancreas, stomach, ovary, <strong>uterus</strong>, lungs, and kidneys are at the&nbsp;highest risk of venous thromboembolism (VTE) development.</p>\n<p>Advanced, metastatic cancer has been shown to be associated with an increased risk of VTE compared with localized tumors.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4138",
      "difficulty": "medium"
    },
    {
      "text": "A 24-year-old patient with paroxysmal hypertension is suspected to have malignant pheochromocytoma. Which of the following tumor markers will help you confirm your diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Calcitonin"
        },
        {
          "id": 2,
          "text": "Catecholamine"
        },
        {
          "id": 3,
          "text": "α-fetoprotein"
        },
        {
          "id": 4,
          "text": "Carcinoembryonic antigen"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The serum levels of <strong>catecholamines</strong> are elevated in malignant <strong>pheochromocytoma</strong>. Extra-adrenal location is the only criteria for malignancy in pheochromocytoma.</p>\n<p><strong>Pheochromocytoma</strong>&nbsp;is a rare&nbsp;<strong>catecholamine-secreting tumor</strong> that may precipitate life-threatening <strong>hypertension</strong>.&nbsp;It is classically associated with three syndromes:</p>\n<ul>\n<li>von Hippel-Lindau (<strong>VHL</strong>) syndrome</li>\n<li>Multiple endocrine neoplasia type 2 (<strong>MEN 2</strong>)</li>\n<li>Neurofibromatosis type 1 (<strong>NF1</strong>)</li>\n</ul>\n<p><strong>Catecholamines</strong> produced by pheochromocytomas are metabolized within chromaffin cells. <strong>Norepinephrine</strong> is metabolized to <strong>normetanephrine,</strong> and <strong>epinephrine</strong> is metabolized to <strong>metanephrine</strong>. Because this process occurs within the tumor, independent of catecholamine release, pheochromocytomas are best diagnosed by the measurement of these metabolites, rather than by measurement of the parent catecholamines.</p><hr><h3>Related Pearl: Tumor Markers</h3><p><strong>Tumor Markers</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Tumor Markers</strong></p>\n</td>\n<td>\n<p><strong>Tumor Types</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Hormones</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Human chorionic gonadotropin</p>\n</td>\n<td>\n<p>Trophoblastic tumors, nonseminonmatous testicular tumors</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Calcitonin</p>\n</td>\n<td>\n<p>Medullary carcinoma of thyroid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Catecholamine and metabolites</p>\n</td>\n<td>\n<p>Pheochromocytoma and related tumors</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Oncofetal Antigens</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&alpha;-Fetoprotein</p>\n</td>\n<td>\n<p>Liver cell cancer, nonseminonmatous germ-cell tumors of the&nbsp;testis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Carcinoembryonic antigen</p>\n</td>\n<td>\n<p>Carcinomas of the colon, lung, stomach, and heart</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Enzymes</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Prostatic acid phosphatase</p>\n</td>\n<td>\n<p>Prostate cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Neuron-specific enolase</p>\n</td>\n<td>Small-cell cancer of the lung, neuroblastoma</td>\n</tr>\n<tr>\n<td>\n<p>Lactate dehydrogenase (LDH)</p>\n</td>\n<td>Germ-cell tumors, lymphomas, leukemias</td>\n</tr>\n<tr>\n<td>Thymidine kinase</td>\n<td>Leukemias</td>\n</tr>\n<tr>\n<td>Pyruvate kinase</td>\n<td>Renal cell carcinoma</td>\n</tr>\n<tr>\n<td>Placental alkaline phosphatase</td>\n<td>Seminoma</td>\n</tr>\n<tr>\n<td>\n<p><strong>Specific Proteins</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Immunoglobulins</p>\n</td>\n<td>\n<p>Multiple myeloma and other gammopathies</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Prostate-specific antigen and prostate- specific membrane antigen</p>\n</td>\n<td>\n<p>Prostate cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>NMP 22</p>\n</td>\n<td>\n<p>Bladder cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Mucins and Other Glycoproteins</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>CA-125</p>\n</td>\n<td>\n<p>Ovarian cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>CA- 19-9</p>\n</td>\n<td>\n<p>Colon cancer, pancreatic cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>CA-15-3</p>\n</td>\n<td>\n<p>Breast cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cell-Free DNA markers</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>TP53, APC, RAS</em> mutants in stool and serum</p>\n</td>\n<td>\n<p>Colon cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>TP53, RAS</em> mutants in stool and serum</p>\n</td>\n<td>\n<p>Pancreatic cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>TP53, RAS</em> mutants in sputum and serum</p>\n</td>\n<td>\n<p>Lung cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>TP53</em> mutants in urine</p>\n</td>\n<td>\n<p>Bladder cancer</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>NMP: Nuclear matrix protein</p>\n<p>CA: Carbohydrate antigen</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4139",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following are oncofetal antigens?<div class='question-desc-html'><ol>\n<li>&alpha;-fetoprotein</li>\n<li>Carcinoembryonic antigen</li>\n<li>Human chorionic gonadotropin</li>\n<li>Placental alkaline phosphatase</li>\n<li>Immunoglobulins</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1 and 3"
        },
        {
          "id": 2,
          "text": "1, 3 and 4"
        },
        {
          "id": 3,
          "text": "3, 4 and 5"
        },
        {
          "id": 4,
          "text": "1 and 2"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Alpha-fetoprotein </strong>(AFP)<strong>&nbsp;</strong>and<strong> carcinoembryonic antigen</strong> (CEA)&nbsp;are oncofetal antigens.</p>\n<p><strong>Alpha-fetoprotein</strong> is a valuable clinical aid in diagnosis, prognosis, and monitoring of the following tumors:</p>\n<ul>\n<li>Primary hepatocellular carcinoma</li>\n<li>Hepatoblastoma</li>\n<li>Non-seminomatous testicular germ cell tumors</li>\n<li>Embryonal carcinoma</li>\n<li>Teratomas</li>\n<li>Choriocarcinoma</li>\n<li>Yolk sac carcinoma</li>\n<li>Germ cell tumors of the&nbsp;ovary and extragonadal germ cell tumors</li>\n</ul>\n<p><strong>Regenerated hepatic tissue</strong> following liver damage due to viral hepatitis, chemically induced necrosis, and liver surgery are associated with moderately <strong>raised</strong> serum <strong>AFP</strong> levels.</p>\n<p><strong>Carcinoembryonic antigen</strong> is normally detected in <strong>glycocalyx</strong> of fetal epithelial cells.&nbsp;It is useful in detection, assessing recurrence, and&nbsp;prognosis of the following tumors:</p>\n<ul>\n<li>Adenocarcinoma of lung</li>\n<li>Colorectal carcinoma</li>\n</ul>\n<p>CEA levels <strong>&gt;5 ng/dL</strong> are noted in ascites fluid associated with <strong>malignancy</strong>. Canalicular pattern for polyclonal CEA more sensitive for hepatocellular carcinoma, metastases in pancreatic adenocarcinoma&nbsp;and not sensitive for metastasis in bile duct adenoma.</p>\n<p>Elevated levels are also present in the following <strong>non-neoplastic</strong> conditions:</p>\n<ul>\n<li>Cirrhosis</li>\n<li>Biliary obstruction</li>\n<li>Hepatitis</li>\n<li>Inflammatory bowel disease</li>\n<li>Smokers</li>\n<li>Post-surgical bowel sequestration</li>\n<li>Mucocele</li>\n<li>Benign cysts may be positive for carcinoembryonic antigen</li>\n</ul><hr><h3>Related Pearl: Tumor Markers</h3><p><strong>Tumor Markers</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Tumor Markers</strong></p>\n</td>\n<td>\n<p><strong>Tumor Types</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Hormones</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Human chorionic gonadotropin</p>\n</td>\n<td>\n<p>Trophoblastic tumors, nonseminonmatous testicular tumors</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Calcitonin</p>\n</td>\n<td>\n<p>Medullary carcinoma of thyroid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Catecholamine and metabolites</p>\n</td>\n<td>\n<p>Pheochromocytoma and related tumors</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Oncofetal Antigens</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&alpha;-Fetoprotein</p>\n</td>\n<td>\n<p>Liver cell cancer, nonseminonmatous germ-cell tumors of the&nbsp;testis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Carcinoembryonic antigen</p>\n</td>\n<td>\n<p>Carcinomas of the colon, lung, stomach, and heart</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Enzymes</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Prostatic acid phosphatase</p>\n</td>\n<td>\n<p>Prostate cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Neuron-specific enolase</p>\n</td>\n<td>Small-cell cancer of the lung, neuroblastoma</td>\n</tr>\n<tr>\n<td>\n<p>Lactate dehydrogenase (LDH)</p>\n</td>\n<td>Germ-cell tumors, lymphomas, leukemias</td>\n</tr>\n<tr>\n<td>Thymidine kinase</td>\n<td>Leukemias</td>\n</tr>\n<tr>\n<td>Pyruvate kinase</td>\n<td>Renal cell carcinoma</td>\n</tr>\n<tr>\n<td>Placental alkaline phosphatase</td>\n<td>Seminoma</td>\n</tr>\n<tr>\n<td>\n<p><strong>Specific Proteins</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Immunoglobulins</p>\n</td>\n<td>\n<p>Multiple myeloma and other gammopathies</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Prostate-specific antigen and prostate- specific membrane antigen</p>\n</td>\n<td>\n<p>Prostate cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>NMP 22</p>\n</td>\n<td>\n<p>Bladder cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Mucins and Other Glycoproteins</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>CA-125</p>\n</td>\n<td>\n<p>Ovarian cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>CA- 19-9</p>\n</td>\n<td>\n<p>Colon cancer, pancreatic cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>CA-15-3</p>\n</td>\n<td>\n<p>Breast cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cell-Free DNA markers</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>TP53, APC, RAS</em> mutants in stool and serum</p>\n</td>\n<td>\n<p>Colon cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>TP53, RAS</em> mutants in stool and serum</p>\n</td>\n<td>\n<p>Pancreatic cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>TP53, RAS</em> mutants in sputum and serum</p>\n</td>\n<td>\n<p>Lung cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>TP53</em> mutants in urine</p>\n</td>\n<td>\n<p>Bladder cancer</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>NMP: Nuclear matrix protein</p>\n<p>CA: Carbohydrate antigen</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4141",
      "difficulty": "medium"
    },
    {
      "text": "A 42-year-old patient is diagnosed with breast cancer. Which of the following glycoproteins is expected to be elevated in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "CA-125"
        },
        {
          "id": 2,
          "text": "CA-19-9"
        },
        {
          "id": 3,
          "text": "CA-15-3"
        },
        {
          "id": 4,
          "text": "CA-5-13"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The level of cancer antigen 15-3 (<strong>CA 15-3</strong>) is elevated in patients with&nbsp;<strong>breast cancer</strong>.</p>\n<p>The reference range of serum CA 15-3 is less than <strong>30 U/mL.&nbsp;</strong>It is used to monitor<strong> response </strong>to breast cancer<strong> treatment</strong> and disease <strong>recurrence</strong>.&nbsp;</p><hr><h3>Related Pearl: Tumor Markers</h3><p><strong>Tumor Markers</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Tumor Markers</strong></p>\n</td>\n<td>\n<p><strong>Tumor Types</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Hormones</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Human chorionic gonadotropin</p>\n</td>\n<td>\n<p>Trophoblastic tumors, nonseminonmatous testicular tumors</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Calcitonin</p>\n</td>\n<td>\n<p>Medullary carcinoma of thyroid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Catecholamine and metabolites</p>\n</td>\n<td>\n<p>Pheochromocytoma and related tumors</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Oncofetal Antigens</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&alpha;-Fetoprotein</p>\n</td>\n<td>\n<p>Liver cell cancer, nonseminonmatous germ-cell tumors of the&nbsp;testis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Carcinoembryonic antigen</p>\n</td>\n<td>\n<p>Carcinomas of the colon, lung, stomach, and heart</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Enzymes</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Prostatic acid phosphatase</p>\n</td>\n<td>\n<p>Prostate cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Neuron-specific enolase</p>\n</td>\n<td>Small-cell cancer of the lung, neuroblastoma</td>\n</tr>\n<tr>\n<td>\n<p>Lactate dehydrogenase (LDH)</p>\n</td>\n<td>Germ-cell tumors, lymphomas, leukemias</td>\n</tr>\n<tr>\n<td>Thymidine kinase</td>\n<td>Leukemias</td>\n</tr>\n<tr>\n<td>Pyruvate kinase</td>\n<td>Renal cell carcinoma</td>\n</tr>\n<tr>\n<td>Placental alkaline phosphatase</td>\n<td>Seminoma</td>\n</tr>\n<tr>\n<td>\n<p><strong>Specific Proteins</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Immunoglobulins</p>\n</td>\n<td>\n<p>Multiple myeloma and other gammopathies</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Prostate-specific antigen and prostate- specific membrane antigen</p>\n</td>\n<td>\n<p>Prostate cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>NMP 22</p>\n</td>\n<td>\n<p>Bladder cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Mucins and Other Glycoproteins</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>CA-125</p>\n</td>\n<td>\n<p>Ovarian cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>CA- 19-9</p>\n</td>\n<td>\n<p>Colon cancer, pancreatic cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>CA-15-3</p>\n</td>\n<td>\n<p>Breast cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cell-Free DNA markers</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>TP53, APC, RAS</em> mutants in stool and serum</p>\n</td>\n<td>\n<p>Colon cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>TP53, RAS</em> mutants in stool and serum</p>\n</td>\n<td>\n<p>Pancreatic cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>TP53, RAS</em> mutants in sputum and serum</p>\n</td>\n<td>\n<p>Lung cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>TP53</em> mutants in urine</p>\n</td>\n<td>\n<p>Bladder cancer</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>NMP: Nuclear matrix protein</p>\n<p>CA: Carbohydrate antigen</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4143",
      "difficulty": "medium"
    },
    {
      "text": "A 51-year-old male patient who is a chronic smoker presents with dry persistent cough and progressive dyspnea. You are suspecting small cell carcinoma of lung. Which of the following tumor markers is likely to be elevated in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Lactate dehydrogenase"
        },
        {
          "id": 2,
          "text": "Acid phosphatase"
        },
        {
          "id": 3,
          "text": "Neuron-specific enolase"
        },
        {
          "id": 4,
          "text": "Thymidine kinase"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario is suggestive of <strong>small cell carcinoma</strong> of the <strong>lung</strong> (SCLC) in which levels of<strong> neuron-specific enolase </strong>(NSE)&nbsp;are elevated.</p>\n<p><strong>NSE</strong>&nbsp;is also called gamma enolase or enolase 2 (ENO2) and is encoded by <strong>ENO2</strong> <strong>gene</strong>. It is a phosphopyruvate hydratase that is produced by small-cell lung carcinomas, which are <strong>neuroendocrine </strong>in origin. Their levels&nbsp;have been implicated as a <strong>prognostic</strong> <strong>factor</strong> for patients with small-cell lung cancer.</p><hr><h3>Related Pearl: Tumor Markers</h3><p><strong>Tumor Markers</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Tumor Markers</strong></p>\n</td>\n<td>\n<p><strong>Tumor Types</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Hormones</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Human chorionic gonadotropin</p>\n</td>\n<td>\n<p>Trophoblastic tumors, nonseminonmatous testicular tumors</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Calcitonin</p>\n</td>\n<td>\n<p>Medullary carcinoma of thyroid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Catecholamine and metabolites</p>\n</td>\n<td>\n<p>Pheochromocytoma and related tumors</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Oncofetal Antigens</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&alpha;-Fetoprotein</p>\n</td>\n<td>\n<p>Liver cell cancer, nonseminonmatous germ-cell tumors of the&nbsp;testis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Carcinoembryonic antigen</p>\n</td>\n<td>\n<p>Carcinomas of the colon, lung, stomach, and heart</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Enzymes</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Prostatic acid phosphatase</p>\n</td>\n<td>\n<p>Prostate cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Neuron-specific enolase</p>\n</td>\n<td>Small-cell cancer of the lung, neuroblastoma</td>\n</tr>\n<tr>\n<td>\n<p>Lactate dehydrogenase (LDH)</p>\n</td>\n<td>Germ-cell tumors, lymphomas, leukemias</td>\n</tr>\n<tr>\n<td>Thymidine kinase</td>\n<td>Leukemias</td>\n</tr>\n<tr>\n<td>Pyruvate kinase</td>\n<td>Renal cell carcinoma</td>\n</tr>\n<tr>\n<td>Placental alkaline phosphatase</td>\n<td>Seminoma</td>\n</tr>\n<tr>\n<td>\n<p><strong>Specific Proteins</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Immunoglobulins</p>\n</td>\n<td>\n<p>Multiple myeloma and other gammopathies</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Prostate-specific antigen and prostate- specific membrane antigen</p>\n</td>\n<td>\n<p>Prostate cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>NMP 22</p>\n</td>\n<td>\n<p>Bladder cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Mucins and Other Glycoproteins</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>CA-125</p>\n</td>\n<td>\n<p>Ovarian cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>CA- 19-9</p>\n</td>\n<td>\n<p>Colon cancer, pancreatic cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>CA-15-3</p>\n</td>\n<td>\n<p>Breast cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cell-Free DNA markers</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>TP53, APC, RAS</em> mutants in stool and serum</p>\n</td>\n<td>\n<p>Colon cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>TP53, RAS</em> mutants in stool and serum</p>\n</td>\n<td>\n<p>Pancreatic cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>TP53, RAS</em> mutants in sputum and serum</p>\n</td>\n<td>\n<p>Lung cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>TP53</em> mutants in urine</p>\n</td>\n<td>\n<p>Bladder cancer</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>NMP: Nuclear matrix protein</p>\n<p>CA: Carbohydrate antigen</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4309",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not a marker for gastrointestinal stromal tumors?",
      "choices": [
        {
          "id": 1,
          "text": "KIT"
        },
        {
          "id": 2,
          "text": "SDH"
        },
        {
          "id": 3,
          "text": "PDGFRA"
        },
        {
          "id": 4,
          "text": "NRG-1"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>NRG-1</strong> (Neuregulin-1) is not a marker for <strong>gastrointestinal stromal tumors</strong> (GISTs).</p>\n<p><strong>GIST</strong> are the most common <strong>mesenchymal</strong> tumor of the <strong>abdomen,</strong> the <strong>stomach</strong> being the most common site. They arise from the <strong>interstitial cells</strong> of <strong>Cajal,</strong> the pacemaker cells of the GIT. GIST is seen in the <strong>5th</strong> to <strong>6th decade</strong> of life and has an <strong>equal preponderance</strong> among males and females. Most patients present with <strong>haematemesis, melena,</strong> or <strong>vague abdominal</strong> pain. The most common indications for surgery include <strong>bleeding</strong> and <strong>obstruction.</strong></p>\n<p>The GIST may occur in a <strong>sporadic</strong> form or as part of <strong>familial syndromes.</strong> In sporadic GIST, the most common mutations seen are gain-of-function mutation in KIT (75-80%) and PDGFRA mutation (8%). Microscopically, GIST has <strong>elongated spindle cells</strong> or plumper epithelioid cells, or a mixed pattern.</p>\n<p>The below image shows the microscopy of GIST composed of bundles, or fascicles, of spindle-shaped tumor cells.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a9bf9b67e36847358296aa149b9b4ea8x1280x1033.JPEG\" alt=\"Explanation Image\"><p><strong>Succinate dehydrogenase</strong> (SDH)-deficient GIST is a subset of wild-type GIST seen with Carney triad or Carney-Stratakis syndrome. </p>\n<p><strong>Imatinib</strong> can be used to treat GIST with mutations in <strong>KIT</strong> or <strong>PDGFRA.</strong> Succinate dehydrogenase (SDH) - deficient GIST is imatinib-resistant, so sunitinib, sorafenib, or regorafenib can be used instead. </p>\n<p>During surgical resection of GIST, care must be taken to prevent capsule rupture, which causes <strong>seeding</strong> of <strong>nearby tissues</strong> leading to <strong>relapse</strong> in <strong>100%</strong> of the <strong>cases.</strong> If capsule rupture occurs, adjuvant therapy with imatinib is indicated regardless of tumor extent.</p>\n<p>Other options:</p>\n<p>Option A: <strong>KIT (CD117):</strong> This is the most well-known marker for GISTs. About 85% of GISTs show mutations in the KIT gene, leading to the expression of the KIT protein on the cell surface. KIT is a receptor tyrosine kinase, and its activation is a key driver in the pathogenesis of GISTs.</p>\n<p>Option B: <strong>SDH (Succinate</strong> Dehydrogenase): SDH mutations are associated with a subset of GISTs, particularly those that are KIT and PDGFRA wild-type. Loss of SDH function is characteristic of this subgroup, and SDH deficiency can be demonstrated through immunohistochemistry.</p>\n<p>Option C: <strong>PDGFRA</strong> (Platelet-Derived Growth Factor Receptor Alpha): Mutations in the PDGFRA gene account for approximately 5-10% of GISTs. Similar to KIT, PDGFRA is a receptor tyrosine kinase, and mutations in this gene can lead to the development of GISTs.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG6675",
      "difficulty": "medium"
    }
  ]
}